MedPath

Ethamolin

Ethamolin® (Ethanolamine Oleate) Injection, 5%. For Local Intravenous Use Only Rx only

Approved
Approval ID

a9c1d8c5-443e-400e-a42c-16a25fb47231

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 15, 2023

Manufacturers
FDA

QOL Medical, LLC.

DUNS: 140026258

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ethanolamine Oleate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code67871-479
Application NumberNDA019357
Product Classification
M
Marketing Category
C73594
G
Generic Name
Ethanolamine Oleate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 15, 2023
FDA Product Classification

INGREDIENTS (3)

BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
ETHANOLAMINE OLEATEActive
Quantity: 50 mg in 1 mL
Code: U4RY8MRX7C
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ethamolin - FDA Drug Approval Details